Jenny L Gerster

Title: Jenny L Gerster: Innovator in Pharmaceutical Crystallization

Introduction

Jenny L Gerster is a notable inventor based in Brantford, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the area of crystalline forms of various compounds. With a total of 4 patents to her name, her work has implications for the treatment of various medical conditions.

Latest Patents

Among her latest patents is the invention of a novel crystalline form of Valbenazine dibesylate. This invention provides a new crystalline form, known as Valbenazine dibesylate Form APO-I, along with compositions and processes for its preparation. This crystalline form is particularly useful in the treatment of hyperkinetic disorders, including tardive dyskinesia. Another significant patent involves the crystalline forms of Ponatinib hydrochloride. This invention presents several novel crystalline forms, including Ponatinib hydrochloride Form APO-I, APO-III, and APO-IV, which are obtained from acetonitrile/formic acid solutions. Additionally, Form APO-V is introduced, which is derived from concentrated hydrochloric acid.

Career Highlights

Jenny L Gerster is currently associated with Apotex Inc., a leading pharmaceutical company. Her work at Apotex has allowed her to focus on innovative solutions in drug formulation and delivery. Her contributions have been instrumental in advancing the understanding of crystalline forms and their applications in medicine.

Collaborations

Throughout her career, Jenny has collaborated with esteemed colleagues, including Allan W Rey and Katherine A Rantanen. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Jenny L Gerster's work exemplifies the importance of innovation in the pharmaceutical industry. Her patents not only contribute to scientific knowledge but also have the potential to improve patient care through advanced treatment options.